This Solicitation opportunity from Department Of Defense was posted on May 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
TRAZODONE TABLETS, U
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract entails the procurement of Trazodone Tablets, USP, with each tablet containing 50 mg of trazodone hydrochloride. The medication is prescription-only and supplied in bottles containing 100 tablets each. The product must have a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the first government facility. Storage conditions require controlled room temperature between 20° to 25°C (68° to 77°F). The packaging and labeling must comply with stringent requirements, including the presence of the National Stock Number, manufacturer details, manufacturing and expiration dates, contract and lot numbers, and adherence to medical marking standards as outlined by the Defense Logistics Agency (DLA). Packaging must be commercial with sealed containers that protect against damage during transit. The government requires all units to be delivered within 10 days to the specified destination, and the inspection and acceptance will occur at that delivery point. The contract references multiple technical and quality requirements from the DLA Master List, covering packaging, marking, and handling, including procedures for hazardous materials if applicable. The product is regulated by the FDA, and a confirmation process by a contracting official is mandated. Supplied by manufacturers such as Teva Pharmaceuticals USA and Apotex Corp., the contract includes detailed specifications about the packaging, palletization, and shipment to ensure safe, cost-effective delivery to the designated military medical facility in Baumholder, Germany. All procurement details, including contact points and documentation, are managed through the Department of Defense’s acquisition systems.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
TRAZODONE TABLETS<(>,<)> USP
EACH TABLET CONTAINS: 50 MG TRAZODONE HYDROCHLORIDE, USP.
RX ONLY.
UNIT OF ISSUE IS A BOTTLE CONTAINING 100 TABLETS EACH
TOTAL SHELF LIFE IS 24 MONTHS. THERE SHALL BE A MINIMUM OF 21 MONTHS OF
TOTAL SHELF LIFE REMAINING AT THE TIME OF RECEIPT BY THE FIRST
GOVERNMENT ACTIVITY.
STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM
TEMPERATURE].
LABELING AND MARKING: MUST INCLUDE THE FOLLOWING: NATIONAL STOCK NUMBER,
MANUFACTURER, DATE OF MANUFACTURER, EXPIRATION DATE OR RETEST DATE,
CONTRACT NUMBER AND LOT NUMBER
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
SPE2DP-26-T-3391
SECTION B
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC50111-0560-01 APOTEX CORP. 4PX51 P/N NDC60505-2653-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016764732 0001 BT 1.000
NSN/MATERIAL:6505011374627
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SPE2DP-26-T-3391
SECTION B
PR: 7016764732 PRLI: 0001 CONT’D
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
MARKFOR
W50YF3
0008 MD CO MEDICAL LOGISTI
8TH MLC TASL MEDICAL BLDG 8343
SMITH BKS AULENBACHERSTR
BAUMHOLDER 55774
DE
M/F: (TCN) W50YF361320002
RDD: 146
PROJ: 9GU TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/15/2026
SPE2DP-26-T-3391 NSN/Part Number: 6505-01-137-4627 Quantity: 1 BT Purchase Request: 7016764732QTY: 1 Delivery: 10 days ADO